Cambridge Biotech gets FDA approval for HTLV-I assay:
This article was originally published in Clinica
Executive Summary
Massachusetts-based Cambridge Biotech's product licence application for its HTLV-I immunoassay has been approved by the US FDA. The company already has five diagnostic tests approved by the FDA and four pending approval.